QQQ   354.65 (+0.75%)
AAPL   180.95 (+0.48%)
MSFT   335.40 (+0.85%)
META   272.61 (+0.00%)
GOOGL   124.67 (+0.77%)
AMZN   124.25 (+1.21%)
TSLA   213.97 (+3.11%)
NVDA   393.27 (-1.11%)
NIO   7.56 (+0.27%)
BABA   84.27 (+1.53%)
AMD   117.86 (-1.35%)
T   15.21 (-3.80%)
F   12.39 (+2.31%)
MU   69.17 (+0.12%)
CGC   0.83 (-1.17%)
GE   105.80 (+1.08%)
DIS   90.77 (+2.46%)
AMC   4.55 (+0.00%)
PFE   38.36 (+0.89%)
PYPL   63.96 (+1.44%)
NFLX   400.47 (-0.66%)
QQQ   354.65 (+0.75%)
AAPL   180.95 (+0.48%)
MSFT   335.40 (+0.85%)
META   272.61 (+0.00%)
GOOGL   124.67 (+0.77%)
AMZN   124.25 (+1.21%)
TSLA   213.97 (+3.11%)
NVDA   393.27 (-1.11%)
NIO   7.56 (+0.27%)
BABA   84.27 (+1.53%)
AMD   117.86 (-1.35%)
T   15.21 (-3.80%)
F   12.39 (+2.31%)
MU   69.17 (+0.12%)
CGC   0.83 (-1.17%)
GE   105.80 (+1.08%)
DIS   90.77 (+2.46%)
AMC   4.55 (+0.00%)
PFE   38.36 (+0.89%)
PYPL   63.96 (+1.44%)
NFLX   400.47 (-0.66%)
QQQ   354.65 (+0.75%)
AAPL   180.95 (+0.48%)
MSFT   335.40 (+0.85%)
META   272.61 (+0.00%)
GOOGL   124.67 (+0.77%)
AMZN   124.25 (+1.21%)
TSLA   213.97 (+3.11%)
NVDA   393.27 (-1.11%)
NIO   7.56 (+0.27%)
BABA   84.27 (+1.53%)
AMD   117.86 (-1.35%)
T   15.21 (-3.80%)
F   12.39 (+2.31%)
MU   69.17 (+0.12%)
CGC   0.83 (-1.17%)
GE   105.80 (+1.08%)
DIS   90.77 (+2.46%)
AMC   4.55 (+0.00%)
PFE   38.36 (+0.89%)
PYPL   63.96 (+1.44%)
NFLX   400.47 (-0.66%)
QQQ   354.65 (+0.75%)
AAPL   180.95 (+0.48%)
MSFT   335.40 (+0.85%)
META   272.61 (+0.00%)
GOOGL   124.67 (+0.77%)
AMZN   124.25 (+1.21%)
TSLA   213.97 (+3.11%)
NVDA   393.27 (-1.11%)
NIO   7.56 (+0.27%)
BABA   84.27 (+1.53%)
AMD   117.86 (-1.35%)
T   15.21 (-3.80%)
F   12.39 (+2.31%)
MU   69.17 (+0.12%)
CGC   0.83 (-1.17%)
GE   105.80 (+1.08%)
DIS   90.77 (+2.46%)
AMC   4.55 (+0.00%)
PFE   38.36 (+0.89%)
PYPL   63.96 (+1.44%)
NFLX   400.47 (-0.66%)
NASDAQ:PALI

Palisade Bio (PALI) News Today

$1.39
-0.05 (-3.47%)
(As of 05:22 PM ET)
Compare
Today's Range
$1.37
▼
$1.44
50-Day Range
$1.32
▼
$3.52
52-Week Range
$1.27
▼
$31.00
Volume
111,846 shs
Average Volume
1.39 million shs
Market Capitalization
$9.31 million
P/E Ratio
0.10
Dividend Yield
N/A
Price Target
N/A
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media
Get Palisade Bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for PALI and its competitors with MarketBeat's FREE daily newsletter.



PALI Media Mentions By Week

PALI Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

PALI
News Sentiment
▼
0.48

0.54
▲
Average
Medical
News Sentiment

PALI News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

PALI Articles
This Week
▼
4

2
▲
PALI Articles
Average Week

SourceHeadline
finanznachrichten.de logoPalisade Bio, Inc.: Palisade Bio Promotes J.D. Finley to Chief Executive Officer
finanznachrichten.de - June 1 at 12:57 PM
msn.com logoPalisade Bio appoints J.D. Finley as permanent CEO
msn.com - June 1 at 12:57 PM
finance.yahoo.com logoPalisade Bio Promotes J.D. Finley to Chief Executive Officer
finance.yahoo.com - June 1 at 12:57 PM
MarketBeat logoAnalyzing Genocea Biosciences (NASDAQ:GNCAQ) & Palisade Bio (NASDAQ:PALI)
americanbankingnews.com - May 28 at 2:16 AM
finance.yahoo.com logoPalisade Bio’s LB1148 Two Ongoing Clinical Trials Expecting Topline Data Readouts
finance.yahoo.com - May 24 at 9:55 AM
msn.com logoPalisade Bio, Inc. (PALI) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
msn.com - May 23 at 2:32 PM
MarketBeat logoPalisade Bio (NASDAQ:PALI) Price Target Lowered to $16.00 at LADENBURG THALM/SH SH
americanbankingnews.com - May 19 at 5:47 AM
benzinga.com logoLadenburg Thalmann Maintains Buy on Palisade Bio, Lowers Price Target to $16
benzinga.com - May 18 at 9:59 AM
finance.yahoo.com logoPALISADES ANNOUNCES NEW FOUND GOLD INTERCEPTS AT KEATS WEST
finance.yahoo.com - May 17 at 8:56 AM
msn.com logoLadenburg Thalmann Maintains Palisade Bio (PALI) Buy Recommendation
msn.com - May 17 at 3:56 AM
markets.businessinsider.com logoMaxim Group Keeps Their Buy Rating on Palisade Bio (PALI)
markets.businessinsider.com - May 13 at 12:34 PM
finanznachrichten.de logoPalisade Bio, Inc.: Palisade Bio Reports First Quarter 2023 Financial Results
finanznachrichten.de - May 12 at 9:33 PM
finance.yahoo.com logoPalisade Bio Reports First Quarter 2023 Financial Results
finance.yahoo.com - May 12 at 8:52 AM
finance.yahoo.com logoPalisade Bio Announces Enrollment and Dosing of First Patient in LB1148 Dose Optimization Study
finance.yahoo.com - May 11 at 12:51 PM
MarketBeat logoPalisade Bio (PALI) to Release Earnings on Thursday
americanbankingnews.com - May 10 at 7:30 AM
marketwatch.com logoS-1: PALISADE BIO, INC.
marketwatch.com - April 22 at 4:54 PM
finance.yahoo.com logoPalisade Bio, Inc. (PALI) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
finance.yahoo.com - April 17 at 4:00 PM
benzinga.com logoPremarket Mover: Palisade Bio Inc (PALI) Up 0.96%
benzinga.com - April 12 at 10:01 PM
msn.com logoPalisade (PALI) Enrolls First Patient in LB1148 Study in China
msn.com - April 6 at 8:09 PM
finance.yahoo.com logoPalisade Bio Receives Canadian Patent Covering Composition of Lead Program in Development, LB1148
finance.yahoo.com - April 6 at 10:08 AM
marketwatch.com logoPalisade Bio Shares Rise After First Patient Dosed With Gastrointestinal Drug
marketwatch.com - April 5 at 7:22 PM
finanznachrichten.de logoPalisade Bio, Inc.: Palisade Bio Announces Enrollment of First Patient in Newsoara Phase 3 Clinical Trial Evaluating LB1148
finanznachrichten.de - April 5 at 2:22 PM
seekingalpha.com logoPalisade Bio shares plummet following a $6M registered direct offering
seekingalpha.com - April 5 at 9:21 AM
finance.yahoo.com logoPalisade Bio Announces Enrollment of First Patient in Newsoara Phase 3 Clinical Trial Evaluating LB1148
finance.yahoo.com - April 5 at 9:21 AM
marketwatch.com logoPalisade Bio Shares Down for a Second Day, Declining 10%
marketwatch.com - April 4 at 1:01 PM
marketwatch.com logoPalisade Bio's Shares Drop 35% After $6 Million Direct Offering Prices
marketwatch.com - April 3 at 4:59 PM
msn.com logoWhy Eastside Distilling Shares Are Trading Lower By Over 25%; Here Are 20 Stocks Moving Premarket
msn.com - April 3 at 11:58 AM
msn.com logoWhy Palisade Bio (PALI) Stock Is Diving 30% Lower
msn.com - April 3 at 11:58 AM
finance.yahoo.com logoPalisade Bio Announces $6 Million Registered Direct Offering and Concurrent Private Placement Priced Above Market Under Nasdaq Rules
finance.yahoo.com - April 3 at 11:58 AM
investorplace.com logoWhy Is Palisade Bio (PALI) Stock Up 36% Today?
investorplace.com - March 31 at 9:08 AM
MarketBeat logoPalisade Bio (NASDAQ:PALI) Upgraded by Maxim Group to "Buy"
americanbankingnews.com - March 31 at 6:46 AM
benzinga.com logo'What Makes Palisade Bio, Inc. A New Buy Stock' - Zacks Research
benzinga.com - March 31 at 4:41 AM
msn.com logoMaxim Group Upgrades Palisade Bio (PALI)
msn.com - March 30 at 10:29 PM
msn.com logoBenzinga's Top Ratings Upgrades, Downgrades For March 30, 2023
msn.com - March 30 at 12:28 PM
benzinga.com logoPalisade Bio shares are trading higher after Maxim Group upgraded the stock from Hold to Buy and announced a $50 price target.
benzinga.com - March 30 at 12:28 PM
finance.yahoo.com logoWhat Makes Palisade Bio, Inc. (PALI) a New Buy Stock
finance.yahoo.com - March 29 at 6:31 PM
finanznachrichten.de logoPalisade Bio, Inc.: Palisade Bio Reports Year End 2022 Financial Results and Provides Corporate Update
finanznachrichten.de - March 23 at 1:04 PM
finance.yahoo.com logoPalisade Bio Reports Year End 2022 Financial Results and Provides Corporate Update
finance.yahoo.com - March 23 at 1:04 PM
afr.com logoRich Lister’s $100m investment in ‘huge commercial opportunity’
afr.com - March 21 at 5:28 PM
finance.yahoo.com logoPALISADES ANNOUNCES NEW FOUND'S INCREASED WEIGHTING BY GDXJ
finance.yahoo.com - March 15 at 12:00 PM
msn.com logoPalisade rises on upcoming EU patent linked to LB1148 for post-surgical abdominal adhesions
msn.com - March 1 at 1:40 PM
finance.yahoo.com logoPalisade Bio Receives Intention to Grant from European Patent Office for LB1148 Patent
finance.yahoo.com - March 1 at 1:40 PM
finance.yahoo.com logoPalisade Bio Promotes Robert McRae to Chief Operating Officer
finance.yahoo.com - February 8 at 10:21 AM
seekingalpha.com logoPALI Palisade Bio, Inc.
seekingalpha.com - January 21 at 6:46 PM
finance.yahoo.com logoPalisade Bio Further Strengthens Balance Sheet with Early Exercise of Warrants Resulting in Cash Proceeds of $4.9 Million
finance.yahoo.com - January 10 at 12:42 PM
finance.yahoo.com logoPalisade Bio Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private Placement Priced Above Market Under Nasdaq Rules
finance.yahoo.com - January 4 at 6:11 PM
marketwatch.com logoPalisade Bio Shares Drop 19%, Reversing Gains From $2.5M Direct Offering
marketwatch.com - January 3 at 3:26 PM
msn.com logoPalisade Bio stock jumps ~29% on $2.5M direct offering, private placement
msn.com - December 31 at 11:11 AM
marketbeat.com logo
marketbeat.com - December 30 at 10:54 AM
marketwatch.com logoPalisade Bio Shares Surge After $2.5M Direct Offering
marketwatch.com - December 30 at 10:49 AM
Get Palisade Bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for PALI and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:PALI) was last updated on 6/2/2023 by MarketBeat.com Staff

My Account -